Mkts

LifeStance Health Group, Inc.

NASDAQ: LFST
$14.08-0.07 (-0.49%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
13.6814.30
52-week range
6.0115.66
Today
Open14.15
Previous close14.08
Volume2.30M
Valuation
Market cap5.35B
P/E ratio74.44×
EPS (TTM)0.18
Income & risk
Dividend / yield—
Beta1.26
Avg volume4.73M
Discussion

LFST News

Stories mentioning LFST from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue403,476382,195363,809345,311332,970325,480312,722312,331
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development
Sales General & Admin100,33094,77795,61597,37594,43193,70685,26995,153
Total Operating Expenses381,192364,111356,399348,261331,366324,421312,675328,278
Operating Income (Loss)22,28418,0847,410(2,950)1,6041,05947.00(15,947)
Interest Income
Interest Expense1,7932,8752,8142,9003,0739,3965,4135,823
Other Expense
Pretax Income19,76015,2034,572(5,942)(1,470)(8,876)(5,382)(22,621)
Tax Provision5,5173,5353,495(2,151)(2,179)(1,764)575.00656.00
Net Income (Loss)14,24311,6681,077(3,791)709.00(13,778)709.00(23,277)
Earnings Per Share (Basic)0.03(0.04)
Earnings Per Share (Diluted)0.03(0.04)
Weighted Average Shares Outstanding (Basic)387,264386,016386,963386,733383,272379,147380,359379,427
Weighted Average Shares Outstanding (Diluted)395,084391,136388,895386,733390,666379,147380,359379,427

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About LFST

LifeStance Health Group, Inc. (NASDAQ: LFST) is a stock listed on the Nasdaq Stock Market under the ticker symbol LFST. It last traded at $14.08 (Nov 13, 2026, 4:00 PM ET), down 0.5% on the day. That gives LifeStance Health a market capitalisation of $5.4B and a price-to-earnings ratio of 74.4.

Over the past 52 weeks LFST has traded between $6.01 and $15.66.

Revenue for the quarter ended Mar 31, 2026 was $403.5M; net income $14.2M. Revenue was up 21.2% from $333.0M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$403.5M$14.2M3.5%
Dec 31, 2025$382.2M$11.7M3.1%
Sep 30, 2025$363.8M$1.1M0.3%
Jun 30, 2025$345.3M-$3.8M-1.1%

From LifeStance Health’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…